PRELIMINARY RESULTS ANNOUNCEMENT for the year ended 31 December 2011

27th March 2012 - 7:31 am

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, is pleased to announce its preliminary audited results for the year ended 31 December 2011.

Share this article

Leave a comment